- Home
- SRRK vs INDV Comparison
SRRK vs INDV Comparison
Compare SRRK & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRRK
- INDV
- Stock Information
- Founded
- SRRK 2012
- INDV 1994
- Country
- SRRK United States
- INDV United States
- Employees
- SRRK N/A
- INDV N/A
- Industry
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- INDV Biotechnology: Pharmaceutical Preparations
- Sector
- SRRK Health Care
- INDV Health Care
- Exchange
- SRRK Nasdaq
- INDV Nasdaq
- Market Cap
- SRRK 3.0B
- INDV 3.1B
- IPO Year
- SRRK 2018
- INDV N/A
- Fundamental
- Price
- SRRK $29.66
- INDV $25.09
- Analyst Decision
- SRRK Strong Buy
- INDV Strong Buy
- Analyst Count
- SRRK 9
- INDV 4
- Target Price
- SRRK $47.88
- INDV $23.75
- AVG Volume (30 Days)
- SRRK 3.2M
- INDV 1.4M
- Earning Date
- SRRK 11-14-2025
- INDV 10-30-2025
- Dividend Yield
- SRRK N/A
- INDV N/A
- EPS Growth
- SRRK N/A
- INDV N/A
- EPS
- SRRK N/A
- INDV 0.42
- Revenue
- SRRK N/A
- INDV $1,173,000,000.00
- Revenue This Year
- SRRK N/A
- INDV N/A
- Revenue Next Year
- SRRK $1,911.27
- INDV $3.00
- P/E Ratio
- SRRK N/A
- INDV $60.72
- Revenue Growth
- SRRK N/A
- INDV 2.27
- 52 Week Low
- SRRK $22.71
- INDV $7.62
- 52 Week High
- SRRK $46.98
- INDV $25.49
- Technical
- Relative Strength Index (RSI)
- SRRK 40.62
- INDV 61.49
- Support Level
- SRRK $29.00
- INDV $23.72
- Resistance Level
- SRRK $29.35
- INDV $25.49
- Average True Range (ATR)
- SRRK 2.50
- INDV 0.77
- MACD
- SRRK -0.81
- INDV 0.07
- Stochastic Oscillator
- SRRK 12.63
- INDV 85.24
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.
About INDV Indivior PLC
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.